Unknown

Dataset Information

0

A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation.


ABSTRACT: Elafin is a serine protease inhibitor produced by epithelial and immune cells with anti-inflammatory properties. Research has shown that dysregulated protease activity may elicit proteolytic cleavage of elafin, thereby impairing the innate immune function of the protein. The aim of this study was to generate variants of elafin (GG- and QQ-elafin) that exhibit increased protease resistance while retaining the biological properties of wild-type (WT) elafin. Similar to WT-elafin, GG- and QQ-elafin variants retained antiprotease activity and susceptibility to transglutaminase-mediated fibronectin cross-linking. However, in contrast to WT-elafin, GG- and QQ-elafin displayed significantly enhanced resistance to degradation when incubated with bronchoalveolar lavage fluid from patients with cystic fibrosis. Intriguingly, both variants, particularly GG-elafin, demonstrated improved lipopolysaccharide (LPS) neutralization properties in vitro. In addition, GG-elafin showed improved anti-inflammatory activity in a mouse model of LPS-induced acute lung inflammation. Inflammatory cell infiltration into the lung was reduced in lungs of mice treated with GG-elafin, predominantly neutrophilic infiltration. A reduction in MCP-1 levels in GG-elafin treated mice compared to the LPS alone treatment group was also demonstrated. GG-elafin showed increased functionality when compared to WT-elafin and may be of future therapeutic relevance in the treatment of lung diseases characterized by a protease burden.

SUBMITTER: Small DM 

PROVIDER: S-EPMC4426794 | biostudies-other | 2015 Jan

REPOSITORIES: biostudies-other

altmetric image

Publications

A functional variant of elafin with improved anti-inflammatory activity for pulmonary inflammation.

Small Donna M DM   Zani Marie-Louise ML   Quinn Derek J DJ   Dallet-Choisy Sandrine S   Glasgow Arlene M A AM   O'Kane Cecilia C   McAuley Danny F DF   McNally Paul P   Weldon Sinéad S   Moreau Thierry T   Taggart Clifford C CC  

Molecular therapy : the journal of the American Society of Gene Therapy 20140905 1


Elafin is a serine protease inhibitor produced by epithelial and immune cells with anti-inflammatory properties. Research has shown that dysregulated protease activity may elicit proteolytic cleavage of elafin, thereby impairing the innate immune function of the protein. The aim of this study was to generate variants of elafin (GG- and QQ-elafin) that exhibit increased protease resistance while retaining the biological properties of wild-type (WT) elafin. Similar to WT-elafin, GG- and QQ-elafin  ...[more]

Similar Datasets

| S-EPMC7665027 | biostudies-literature
| S-EPMC4825432 | biostudies-literature
| S-EPMC9982591 | biostudies-literature
| S-EPMC10384644 | biostudies-literature
| S-EPMC7809280 | biostudies-literature
| S-EPMC9965296 | biostudies-literature
| S-EPMC5742329 | biostudies-literature
2015-08-27 | E-GEOD-72443 | biostudies-arrayexpress
| S-EPMC9947849 | biostudies-literature
| S-EPMC6723478 | biostudies-literature